Advertisement
Product › Details
Alzheimer drug
Record changed: 2024-04-14 |
Advertisement
More documents for Alzheimer drug
- [1] AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London....
- [2] Saniona AB. (7/17/23). "Press Release: Saniona Enters into Collaboration Agreement with AstronauTx in Alzheimer’s Disease"....
- [3] Alzinova AB. (1/24/23). "Press Release: Alzinova Recruits Business Development Director"....
- [4] Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev....
- [5] Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale)....
- [6] Forschungszentrum Jülich. (5/10/19). "Press Release: Alzheimer Therapy from Jülich Passes another Important Test. Drug Candidate PRI-002 Has Successfully Completed Phase I of Clinical Research". Jülich & Vienna....
- [7] Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale)....
- [8] BioArctic AB. (8/7/18). "Press Release: BioArctic Obtains Exclusive Rights to Develop Antibody Treatments for Alzheimer’s Disease from a Research Project Jointly Owned with Eisai". Stockholm....
- [9] H. Lundbeck A/S. (6/6/17). "Press Release: Lundbeck Obtains Rights to Breakthrough Research in Alzheimer's Disease". Valby....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top